Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug 11:2020:9360476.
doi: 10.1155/2020/9360476. eCollection 2020.

A Review of the Dermatological Manifestations of Coronavirus Disease 2019 (COVID-19)

Farah Marraha  1   2 , Ibtissam Al Faker  1   2 , Salim Gallouj  1   2
Affiliations
Review

A Review of the Dermatological Manifestations of Coronavirus Disease 2019 (COVID-19)

Farah Marraha et al. Dermatol Res Pract. .

Abstract

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has affected 210 countries and territories around the world. The virus has spread rapidly, and the disease is still extending up to now. The pathophysiology for SARS-CoV-2 has not been well elucidated, and diverse hypotheses to date have been proposed. Initially, no skin manifestations were observed among patients with COVID-19, but recently a few cases have been described. In this review, we discuss these various cutaneous manifestations and skin problems related to personal protective equipment, as well as different cutaneous anti-COVID-19 drug-associated reactions. We also focus on the currently proposed managements of these rare manifestations.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
(a, b) Scattered erythematous papulovesicles on the trunk in a suspected COVID-19 patient (reprinted from Genovese et al. Varicella-like exanthem associated with COVID-19 in an 8-year-old girl: A diagnostic clue?, Pediatric Dermatology, 37(3), 435–436, Copyright (2020) [35], with permission from Wiley).
Figure 2
Figure 2
Details of the clinical spectrum (reused from Roca-Ginés et al. JAMA Dermatology 2020 [30]; reference under the terms of the CC-BY license, which permits unrestricted use, distribution, and reproduction in any medium). (a) Acral erythema pattern. (b) Dactylitis pattern. (c) Maculopapular purpuric pattern. (d) Mixed patterns.
Figure 3
Figure 3
Contact dermatitis caused by chemical materials in latex gloves (picture is from our department; written consent was provided by the participant).
See this image and copyright information in PMC

References

    1. Rothan H. A., Byrareddy S. N. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmunity. 2020;109 doi: 10.1016/j.jaut.2020.102433.102433 - DOI - PMC - PubMed
    1. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. Journal of the European Academy of Dermatology and Venereology. 2020;34(5) doi: 10.1111/jdv.16387. - DOI - PubMed
    1. Darlenski R., Tsankov N. COVID-19 pandemic and the skin: what should dermatologists know? Clinics in Dermatology. In press. - DOI - PMC - PubMed
    1. Joob B., Wiwanitkit V. COVID-19 can present with a rash and be mistaken for dengue. Journal of the American Academy of Dermatology. 2020;82(5):p. e177. doi: 10.1016/j.jaad.2020.03.036. - DOI - PMC - PubMed
    1. Beylot-Barry L. COVID-19 et lésions cutanées—point d’étape COVIDSKIN de la SFD—15 avril 2020. 2020. https://evenements-sfd.fr/?mailpoet_router&endpoint=view_in_browser&acti....

LinkOut - more resources